Chinese Biotechs Reshuffle Pipeline, Cut Headcount To Stay Afloat

 
• By Dexter Jie Yan
  
save on R&D spending
More Chinese biotechs seek to conserve cash by reshuffling pipelines • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia